AC Immune SA
NASDAQ:ACIU

Watchlist Manager

AC Immune SA

NASDAQ:ACIU

Watchlist

Dividends

Price: 1.88 USD -5.05% Market Closed

Market Cap: 186m USD

Have any thoughts about
AC Immune SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 1.88 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ACIU Alert

AC Immune SA

1.88

-0.10 (-5.05%)

52 Week Range	1.48 4.2
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

AC Immune SA

What unique competitive advantages
does AC Immune SA hold over its rivals?

What risks and challenges
does AC Immune SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of AC Immune SA.

What unique competitive advantages
does AC Immune SA hold over its rivals?

What risks and challenges
does AC Immune SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for AC Immune SA.

Provide P/S
for AC Immune SA.

Provide P/E
for AC Immune SA.

Provide P/OCF
for AC Immune SA.

Provide P/FCFE
for AC Immune SA.

Provide P/B
for AC Immune SA.

Provide EV/S
for AC Immune SA.

Provide EV/GP
for AC Immune SA.

Provide EV/EBITDA
for AC Immune SA.

Provide EV/EBIT
for AC Immune SA.

Provide EV/OCF
for AC Immune SA.

Provide EV/FCFF
for AC Immune SA.

Provide EV/IC
for AC Immune SA.

Show me price targets
for AC Immune SA made by professional analysts.

What are the Revenue projections
for AC Immune SA?

How accurate were the past Revenue estimates
for AC Immune SA?

What are the Net Income projections
for AC Immune SA?

How accurate were the past Net Income estimates
for AC Immune SA?

What are the EPS projections
for AC Immune SA?

How accurate were the past EPS estimates
for AC Immune SA?

What are the EBIT projections
for AC Immune SA?

How accurate were the past EBIT estimates
for AC Immune SA?

Compare the revenue forecasts
for AC Immune SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of AC Immune SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of AC Immune SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of AC Immune SA compared to its peers.

Compare the P/E ratios
of AC Immune SA against its peers.

Discuss the investment returns and shareholder value creation
comparing AC Immune SA with its peers.

Analyze the financial leverage
of AC Immune SA compared to its main competitors.

Show all profitability ratios
for AC Immune SA.

Provide ROE
for AC Immune SA.

Provide ROA
for AC Immune SA.

Provide ROIC
for AC Immune SA.

Provide ROCE
for AC Immune SA.

Provide Gross Margin
for AC Immune SA.

Provide Operating Margin
for AC Immune SA.

Provide Net Margin
for AC Immune SA.

Provide FCF Margin
for AC Immune SA.

Show all solvency ratios
for AC Immune SA.

Provide D/E Ratio
for AC Immune SA.

Provide D/A Ratio
for AC Immune SA.

Provide Interest Coverage Ratio
for AC Immune SA.

Provide Altman Z-Score Ratio
for AC Immune SA.

Provide Quick Ratio
for AC Immune SA.

Provide Current Ratio
for AC Immune SA.

Provide Cash Ratio
for AC Immune SA.

What is the historical Revenue growth
over the last 5 years for AC Immune SA?

What is the historical Net Income growth
over the last 5 years for AC Immune SA?

What is the current Free Cash Flow
of AC Immune SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for AC Immune SA.

P/E
Price to Earnings

-3

Current

-3.6

Median

22.7

Industry

Higher than median

Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E

-3

Market Cap

188.8m USD

Net Income

-52.1m CHF

All Countries

Forward Multiples

			Market Cap	P/E
CH		AC Immune SA NASDAQ:ACIU	188.8m USD	-3
FR		Pharnext SCA OTC:PNEXF	6T USD	-163 805.1
US		Abbvie Inc NYSE:ABBV	327.3B USD	78.8
US		Amgen Inc NASDAQ:AMGN	155.6B USD	26.2
US		Gilead Sciences Inc NASDAQ:GILD	135.1B USD	22.6
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	113.3B USD	-114.6
US	E	Epizyme Inc F:EPE	94.1B EUR	-521.6
AU		CSL Ltd ASX:CSL	116.3B AUD	27.3
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	55.2B USD	12.3
US	S	Seagen Inc F:SGT	39.3B EUR	-60.4
US		Alnylam Pharmaceuticals Inc NASDAQ:ALNY	40.4B USD	-149.6

				Earnings Growth	PEG
CH		AC Immune SA NASDAQ:ACIU	Average P/E: 33.4 Negative Multiple: -3	N/A	N/A
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -163 805.1	N/A	N/A
US		Abbvie Inc NYSE:ABBV	78.8	88%	0.9
US		Amgen Inc NASDAQ:AMGN	26.2	45%	0.6
US		Gilead Sciences Inc NASDAQ:GILD	22.6	188%	0.1
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	Negative Multiple: -114.6	N/A	N/A
US	E	Epizyme Inc F:EPE	Negative Multiple: -521.6	N/A	N/A
AU		CSL Ltd ASX:CSL	27.3	16%	1.7
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	12.3	7%	1.8
US	S	Seagen Inc F:SGT	Negative Multiple: -60.4	N/A	N/A
US		Alnylam Pharmaceuticals Inc NASDAQ:ALNY	Negative Multiple: -149.6	N/A	N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/E

-2

2-Years Forward

P/E

-2.5

3-Years Forward

P/E

15.4

	Franklin Covey Co NYSE:FC	22.27 USD 0.04%
	Mohawk Industries Inc NYSE:MHK	99.53 USD 1.57%
	Ardmore Shipping Corp NYSE:ASC	10.13 USD -3.89%
	ASGN Inc NYSE:ASGN	48.58 USD -1.38%
	Skyworks Solutions Inc NASDAQ:SWKS	72.13 USD 0.71%
	Weatherford International PLC NASDAQ:WFRD	51.04 USD -0.27%

	Johnson & Johnson NYSE:JNJ	149.79 USD -0.62%
	Bank of America Corp NYSE:BAC	45.5 USD 0.98%
	Mastercard Inc NYSE:MA	532.97 USD -1.07%
	Salesforce Inc NYSE:CRM	260.63 USD 0.44%
	Abbvie Inc NYSE:ABBV	185.3 USD -0.1%
	Home Depot Inc NYSE:HD	349.62 USD 0.75%

	Arista Networks Inc NYSE:ANET	86.25 USD -4.42%
	Deckers Outdoor Corp NYSE:DECK	101.69 USD 0.68%
	Visa Inc NYSE:V	338.57 USD -0.53%
	Texas Pacific Land Corp NYSE:TPL	1 084.21 USD 0.41%
	KLA Corp NASDAQ:KLAC	850 USD -2.43%
	Manhattan Associates Inc NASDAQ:MANH	186.29 USD -1.17%

	Salesforce Inc NYSE:CRM	260.63 USD 0.44%
	Accenture PLC NYSE:ACN	285.37 USD -6.86%
	ServiceNow Inc NYSE:NOW	971.41 USD -1.09%
	Spotify Technology SA NYSE:SPOT	707.42 USD -0.39%
	EOG Resources Inc NYSE:EOG	125.32 USD 1.24%
	Applied Materials Inc NASDAQ:AMAT	169.46 USD -1.96%

AC Immune SA
NASDAQ:ACIU

P/E
Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

AC Immune SA NASDAQ:ACIU

P/E Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

AC Immune SA
NASDAQ:ACIU

P/E
Price to Earnings